Evidence map›Paper›PMID 30146559›Full record

ArticleInternal medicine (Tokyo, Japan)2019

Bronchodilator Reversibility Occurring during the Acute Phase of Paragonimiasis westermani Infection.

Tomoya Harada, Yuji Kawasaki, Akira Tsukada, Yoichi Osawa, Hiroki Takami, Kosuke Yamaguchi, Jun Kurai, Akira Yamasaki, Eiji Shimizu

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Tomoya HaradaDivision of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Japan.
Yuji KawasakiDivision of Respirology, Tsuyama Daiichi Hospital, Japan.
Akira TsukadaDepartment of Clinical Laboratory, Tsuyama Daiichi Hospital, Japan.
Yoichi OsawaDepartment of Clinical Laboratory, Tsuyama Daiichi Hospital, Japan.
Hiroki TakamiDivision of Respirology, Tsuyama Daiichi Hospital, Japan.
Kosuke YamaguchiDivision of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Japan.
Jun KuraiDivision of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Japan.
Akira YamasakiDivision of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Japan.
Eiji ShimizuDivision of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Japan.
Tottori University · JPTsuyama Chuo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 43-year-old woman was referred to our hospital with peripheral blood hypereosinophilia and abnormal chest X-ray findings. Her pleural effusion revealed hypereosinophilia and a low glucose level. She was diagnosed with pulmonary paragonimiasis based on an elevated antibody level of Paragonimiasis westermani. Although she had no medical history of allergic disorders, a pulmonary function test revealed bronchodilator reversibility. After praziquantel therapy, her symptoms, hypereosinophilia in peripheral blood, and pleural effusion were improved. A repeated pulmonary function test after praziquantel therapy showed a negative bronchodilator response. Pulmonary paragonimiasis may induce bronchodilator reversibility during the acute phase of infection.

Indexed as

Acute DiseaseAdultAnthelminticsBronchiBronchodilator AgentsEosinophiliaFemaleHumansLung Diseases, ParasiticParagonimiasisPleural EffusionPraziquantelRadiography, ThoracicRespiratory Function TestsAnthelminticsBronchodilator AgentsPraziquantelasthmabronchodilator reversibilityeosinophilParagonimiasis westermanipulmonary paragonimiasis

Identifiers

PMID30146559
PMCPMC6378150
OpenAlexW2888623887

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.